The House passed legislation aimed at capping the out-of-pocket cost for purchasing insulin at $35 a monthh
WASHINGTON—The House passed legislation aimed at capping the out-of-pocket cost for purchasing insulin, with Democrats breaking off a piece of their dormant healthcare, education and climate agenda to try to move the popular provision through Congress.
Under the bill, which passed 232-193, people covered by private health insurance or Medicare’s prescription-drug benefit program would pay no more than $35 a month on insulin beginning in 2023. Twelve House Republicans joined Democrats in support of the bill.
Wir haben diese Nachrichten zusammengefasst, damit Sie sie schnell lesen können. Wenn Sie sich für die Nachrichten interessieren, können Sie den vollständigen Text hier lesen. Weiterlesen: